LegoChem Biosciences Inc (141080.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Life Sciences Tools & Services · South Korea · ISIN KR7141080002
LegoChem Biosciences Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 125.90 bn KRW | 141.55 bn KRW |
| Gross profit | 109.95 bn KRW | 126.00 bn KRW |
| Operating income | -20.95 bn KRW | -106.49 bn KRW |
| EBIT | 9.63 bn KRW | -93.01 bn KRW |
| Net income | 7.80 bn KRW | -74.28 bn KRW |
| Diluted EPS – continuing operations | 214.99 KRW | -2,040.31 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About LegoChem Biosciences Inc
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
More stocks
- Vermilion Energy Inc (VET.TO)
- ADAMA Ltd (000553.SZ)
- Hexing Electrical Co Ltd (603556.SS)
- Luxempart SA (LXMPR.LU)
- Nantong Haixing Electronics Co Ltd (603115.SS)
- Charter Hall Retail REIT (CQR.AX)
- Molten Ventures PLC (GROW.L)
- Etablissements Maurel et Prom SA (MAU.PA)
- Altus Group Ltd (AIF.TO)
- Tokuyama Corp (4043.T)
- Qingdao Haier Biomedical Co Ltd (688139.SS)
- Generate Biomedicines, Inc. Common Stock (GENB)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.